List of bibliographic references indexed by effective
Number of relevant bibliographic references: 725.
[20-40] [
0 - 20][
0 - 50][
40-60]
| Ident. | Authors (with country if any) | Title |
|---|
| 000286 (2020) |
Michele Costanzo ; Maria Anna Rachele De Giglio ; Giovanni Nicola Roviello | SARS CoV-2: Recent Reports on Antiviral Therapies Based on Lopinavir/Ritonavir, Darunavir/Umifenovir, Hydroxychloroquine, Remdesivir, Favipiravir and Other Drugs for the Treatment of the New Coronavirus. |
| 000313 (2020) |
Ka-Tim Choy [République populaire de Chine] ; Alvina Yin-Lam Wong [République populaire de Chine] ; Prathanporn Kaewpreedee [République populaire de Chine] ; Sin Fun Sia [République populaire de Chine] ; Dongdong Chen [République populaire de Chine] ; Kenrie Pui Yan Hui [République populaire de Chine] ; Daniel Ka Wing Chu [République populaire de Chine] ; Michael Chi Wai Chan [République populaire de Chine] ; Peter Pak-Hang Cheung [République populaire de Chine] ; Xuhui Huang [République populaire de Chine] ; Malik Peiris [République populaire de Chine] ; Hui-Ling Yen [République populaire de Chine] | Remdesivir, lopinavir, emetine, and homoharringtonine inhibit SARS-CoV-2 replication in vitro |
| 000314 (2020) |
Calvin J. Gordon [Canada] ; Egor P. Tchesnokov [Canada] ; Emma Woolner [Canada] ; Jason K. Perry [États-Unis] ; Joy Y. Feng [États-Unis] ; Danielle P. Porter [États-Unis] ; Matthias Gotte [Canada] | Remdesivir is a direct-acting antiviral that inhibits RNA-dependent RNA polymerase from severe acute respiratory syndrome coronavirus 2 with high potency. |
| 000330 (2020) |
Tarek Mohamed Abd El-Aziz [États-Unis, Égypte] ; James D. Stockand [États-Unis] | Recent progress and challenges in drug development against COVID-19 coronavirus (SARS-CoV-2) - an update on the status |
| 000332 (2020) |
Minzhe Shen ; Ying Zhou ; Jiawei Ye ; Abdu Ahmed Abdullah Al-Maskri ; Yu Kang ; Su Zeng ; Sheng Cai | Recent advances and perspectives of nucleic acid detection for coronavirus |
| 000355 (2020) |
Houman Khosravani [Canada] ; Phavalan Rajendram [Canada] ; Lowyl Notario [Canada] ; Martin G. Chapman [Canada] ; Bijoy K. Menon [Canada] | Protected Code Stroke: Hyperacute Stroke Management During the Coronavirus Disease 2019 (COVID-19) Pandemic. |
| 000361 (2020) |
Stephen M. Kissler [États-Unis] ; Christine Tedijanto [États-Unis] ; Edward Goldstein [États-Unis] ; Yonatan H. Grad [États-Unis] ; Marc Lipsitch [États-Unis] | Projecting the transmission dynamics of SARS-CoV-2 through the postpandemic
period |
| 000362 (2020) |
Jinyong Zhang [République populaire de Chine] ; Hao Zeng [République populaire de Chine] ; Jiang Gu [République populaire de Chine] ; Haibo Li [République populaire de Chine] ; Lixin Zheng [États-Unis] ; Quanming Zou [République populaire de Chine] | Progress and Prospects on Vaccine Development against SARS-CoV-2. |
| 000380 (2020) |
Yu Wai Chen [Hong Kong] ; Chin-Pang Bennu Yiu [Hong Kong] ; Kwok-Yin Wong [Hong Kong] | Prediction of the SARS-CoV-2 (2019-nCoV) 3C-like protease (3CL
pro) structure: virtual screening reveals velpatasvir, ledipasvir, and other drug repurposing candidates |
| 000385 (2020) |
Giuseppe Rombolà [Italie] ; Marco Hedemperger [Italie] ; Luciano Pedrini [Italie] ; Marco Farina [Italie] ; Filippo Aucella [Italie] ; Piergiorgio Messa [Italie] ; Giuliano Brunori [Italie] | Practical indications for the prevention and management of SARS-CoV-2 in ambulatory dialysis patients: lessons from the first phase of the epidemics in Lombardy |
| 000396 (2020) |
Junxiong Pang [Singapour] ; Min Xian Wang [Singapour] ; Ian Yi Han Ang ; Sharon Hui Xuan Tan ; Ruth Frances Lewis ; Jacinta I-Pei Chen ; Ramona A. Gutierrez ; Sylvia Xiao Wei Gwee [Singapour] ; Pearleen Ee Yong Chua [Singapour] ; Qian Yang ; Xian Yi Ng ; Rowena K. S. Yap ; Hao Yi Tan ; Yik Ying Teo ; Chorh Chuan Tan ; Alex R. Cook ; Jason Chin-Huat Yap ; Li Yang Hsu | Potential Rapid Diagnostics, Vaccine and Therapeutics for 2019 Novel Coronavirus (2019-nCoV): A Systematic Review |
| 000403 (2020) |
Francesco Di Pierro [Oman] ; Alexander Bertuccioli [Italie] ; Ilaria Cavecchia [Italie] | Possible therapeutic role of a highly standardized mixture of active compounds derived from cultured Lentinula edodes mycelia (AHCC) in patients infected with 2019 novel coronavirus. |
| 000405 (2020) |
Youjiang Li [République populaire de Chine] ; Yingying Hu [République populaire de Chine] ; Yuanyuan Yu [République populaire de Chine] ; Xiaodong Zhang [République populaire de Chine] ; Bin Li [République populaire de Chine] ; Jianguo Wu [République populaire de Chine] ; Junyu Li [République populaire de Chine] ; Yingping Wu [République populaire de Chine] ; Xiaoping Xia [République populaire de Chine] ; Huina Tang [République populaire de Chine] ; Jian Xu [République populaire de Chine] | Positive result of Sars-Cov-2 in faeces and sputum from discharged patient with COVID-19 in Yiwu, China. |
| 000416 (2020) |
James M. Sanders [États-Unis] ; Marguerite L. Monogue [États-Unis] ; Tomasz Z. Jodlowski [États-Unis] ; James B. Cutrell [États-Unis] | Pharmacologic Treatments for Coronavirus Disease 2019 (COVID-19): A Review. |
| 000418 (2020) |
Balamurugan Shanmugaraj [Thaïlande] ; Konlavat Siriwattananon [Thaïlande] ; Kittikhun Wangkanont [Thaïlande] ; Waranyoo Phoolcharoen [Thaïlande] | Perspectives on monoclonal antibody therapy as potential therapeutic intervention for Coronavirus disease-19 (COVID-19). |
| 000432 (2020) |
Peong Gang Park [Corée du Sud] ; Chang Hyup Kim [Corée du Sud] ; Yoon Heo [Corée du Sud] ; Tae Suk Kim [Corée du Sud] ; Chan Woo Park [Corée du Sud] ; Choong Hyo Kim [Corée du Sud] | Out-of-Hospital Cohort Treatment of Coronavirus Disease 2019 Patients with Mild Symptoms in Korea: an Experience from a Single Community Treatment Center. |
| 000457 (2020) |
Yadi Zhou [États-Unis] ; Yuan Hou [États-Unis] ; Jiayu Shen [États-Unis] ; Yin Huang [États-Unis] ; William Martin [États-Unis] ; Feixiong Cheng [États-Unis] | Network-based drug repurposing for novel coronavirus 2019-nCoV/SARS-CoV-2 |
| 000458 (2020) |
Shengwei Yu [République populaire de Chine] ; Junwu Wang [République populaire de Chine] ; Haitao Shen [République populaire de Chine] | Network pharmacology-based analysis of the role of traditional Chinese herbal medicines in the treatment of COVID-19. |
| 000469 (2020) |
Hasanain Abdulhameed Odhar [Iraq] ; Salam Waheed Ahjel [Iraq] ; Ali A. Mohammed Ali Albeer [Iraq] ; Ahmed Fadhil Hashim [Iraq] ; Ali Mahmood Rayshan [Iraq] ; Suhad Sami Humadi [Iraq] | Molecular docking and dynamics simulation of FDA approved drugs with the main protease from 2019 novel coronavirus |
| 000474 (2020) |
Paolo Calligari [Italie] ; Sara Bobone [Italie] ; Giorgio Ricci [Italie] ; Alessio Bocedi [Italie] | Molecular Investigation of SARS-CoV-2 Proteins and Their Interactions with Antiviral Drugs. |
| 000477 (2020) |
Hasan Mandal [Turquie] | Mobilizing the research ecosystem for scientific advances towards positive impact in the
context of the COVID-19 Pandemic |
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/AbsEn.i -k "effective"
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/AbsEn.i \
-Sk "effective" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= SrasV1
|flux= Main
|étape= Exploration
|type= indexItem
|index= AbsEn.i
|clé= effective
}}
| This area was generated with Dilib version V0.6.33.
Data generation: Tue Apr 28 14:49:16 2020. Site generation: Sat Mar 27 22:06:49 2021 |  |
